Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 129

Sort by

Sort Order Select

Journal Articles

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border

Alfonso Enrique Bencomo, PhD, Andres J Rubio, MS, Mayra Alejandra Gonzalez, BS, Idaly Maria Olivas, BS, Joshua Lara, BS, Kiran Ghimire, MD, Osvaldo Padilla, MD, Angelica Padilla, MD, Nawar Hakim, MD, Attilio Orazi, MD, Javier Corral, MD, Alexander Philipovskiy, MD PhD, Sumit Gaur, MBBS, Anna M. Eiring, PhD

Blood (2019) 134 (Supplement_1): 4782.

https://doi.org/10.1182/blood-2019-126150

Published: 2019

Journal Articles

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL)

Luis E Malpica Castillo, MD, Camila Peña, MD, Christine Rojas, MD, Pilar León, MD, Brady E. Beltrán, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Mimsy Quinones, MD, Sally Rose Paredes, MD, Henry Idrobo, MD, Ivan Perdomo, MD, Virginia Abello, MD, Lorena Fiad, MD, Victoria Otero, MD, Marialejandra Torres Viera, MD, Luis Villela M, Eduardo Sotomayor, MD, Jorge J Castillo, MD, Juan Carlos Ramos, MD BS

Blood (2019) 134 (Supplement_1): 4045.

https://doi.org/10.1182/blood-2019-122976

Published: 2019

Journal Articles

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

Henry Idrobo, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Sally Rose Paredes, MD, Ivan Perdomo, MD, Pilar León, MD, Christine Rojas, MD, Virginia Abello, MD, Monica Osuna Pérez, MD, Juan Esteban Garcia-Robledo, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2019) 134 (Supplement_1): 4047.

https://doi.org/10.1182/blood-2019-123588

Published: 2019

Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Blood (2019) 134 (Supplement_1): 4121.

https://doi.org/10.1182/blood-2019-127479

Published: 2019

Journal Articles

Pediatric-Inspired Regimens Are Associated with Better Outcomes When Compared with Hypercvad in Hispanic Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Roberta Demichelis, MD, Karla Adriana Espinosa, MD MSc, Juan Rangel-Patiño, MD, Emmanuel Almanza, MD, Ana Cooke, MD

Blood (2019) 134 (Supplement_1): 3877.

https://doi.org/10.1182/blood-2019-125370

Published: 2019

Journal Articles

Changing the Fate of Children with Acute Lymphoblastic Leukemia (ALL) in a Limited Resources Setting

Yajaira Valentine Jimenez-Antolinez, MD, Julia Esther Colunga Pedraza, MD, José Eduardo Mares-Gil, MD, Emma Lizeth Estrada, MD, Jesus Mauricio Gonzalez-Diaz, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD

Blood (2019) 134 (Supplement_1): 5075.

https://doi.org/10.1182/blood-2019-132205

Published: 2019

Journal Articles

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Veronica Bravo Villa, Hematology Fellow, Emmanuel Martínez Moreno, Hematology Fellow, Nidia Zapata, MD

Blood (2019) 134 (Supplement_1): 5114.

https://doi.org/10.1182/blood-2019-128158

Published: 2019

Journal Articles

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5497.

https://doi.org/10.1182/blood-2019-127555

Published: 2019

Journal Articles

Tailored Prophylaxis in Mexican Pediatric Patients with Hemophilia a By Determining the Pharmacokinetics of Factor VIII

Emma Lizeth Estrada, MD, Laura Villarreal, MD, José Eduardo Mares-Gil, MD, Edith Blasquez, MD, Daniel Alejandro García, MD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 4922.

https://doi.org/10.1182/blood-2019-132242

Published: 2019

Journal Articles

Imatinib (IMA) Low Dose Reduction Program (LDR) in Chronic Myeloid Leukemia Ph+ (CML Ph+) in a Single Reference Institution in Mexico City. Ongoing Preliminary Results

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Carrillo Munoz Silvia, RN

Blood (2019) 134 (Supplement_1): 5921.

https://doi.org/10.1182/blood-2019-130873

Published: 2019

Journal Articles

A Modified CALGB-10403 in Hispanic Adolescent and Young Adults with Philadelphia -Negative Acute Lymphoblastic Leukemia: Promising Results Despite a High-Rate of Metabolic and Hepatic Toxicities

Juan Rangel-Patiño, MD, Alvaro Cabrero Garcia, Carolina Balderas-Delgado, MD, Lauro Fabian Amador, MD, Yvette Neme Yunes, Ana Cooke, MD, Adriana Rosas, Roberta Demichelis, MD

Blood (2019) 134 (Supplement_1): 1352.

https://doi.org/10.1182/blood-2019-126108

Published: 2019

Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Blood (2019) 134 (Supplement_1): 1613.

https://doi.org/10.1182/blood-2019-123841

Published: 2019

Journal Articles

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Christianne Bourlon, MD, Oscar Manuel Fierro-Angulo, MD, Jesus A Garcia-Ramos, MD, Rocio Camacho-Hernandez, MD, Roberta Demichelis, MD, Aldo A Acosta-Medina, MS

Blood (2019) 134 (Supplement_1): 3259.

https://doi.org/10.1182/blood-2019-131425

Published: 2019

Journal Articles

Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

Elisa Quiroz, MD, Rebecca Nelson, MD, Vinod A. Pullarkat, MD, Ibrahim Aldoss, Thomas Slavin, MD, Eduardo Magalhães Rego, MD PhD, Guido Marcucci, Dan Douer, MD

Blood (2018) 132 (Supplement 1): 2816.

https://doi.org/10.1182/blood-2018-99-119962

Published: 2018

Journal Articles

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Eloisa Riva, MD, Natalia Paola Schutz, MD, Camila Peña, MD, Fiorella Villano, MD, Guillermo J. Ruiz-Argüelles, FRCP, MACP, Juan Ramon Navarro, MD, Willem Bujan, MD, Lidiane Andino Neves, MD, Christine Rojas, MD, Hernán López-Vidal, MD, Angelina Rodriguez, MD, Virginia Bove, MD, Miguel Rodriguez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 2244.

https://doi.org/10.1182/blood-2018-99-111429

Published: 2018

Journal Articles

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Nidia Zapata, MD, Espinoza Ramiro, III, Eduardo Cervera, Judith Cruz, MD, Diana Arcos, MD, Juan Labardini, MD

Blood (2018) 132 (Supplement 1): 5197.

https://doi.org/10.1182/blood-2018-99-115300

Published: 2018

Journal Articles

Role of Bone Marrow Infiltration and POD 24 in Follicular Lymphoma

Silvia Rivas-Vera, MD, Brenda Lizeth Acosta-Maldonado, MD, Lizeth Elisua Estrada-Martínez, MDcal student

Blood (2018) 132 (Supplement 1): 5336.

https://doi.org/10.1182/blood-2018-99-120066

Published: 2018

Journal Articles

Leukocytosis, but Not Thrombocytosis, May Constitute a Prothrombotic Pathway in Women with Ovarian Cancer: A Cohort Study

Javier Lopez Salazar, Laura A Ramirez Tirado, MD, Nora Gomez Contreras, MD, Oscar Arrieta, MD PhD, Dolores Gallardo, MD, Gabriela Cesarman-Maus, MD PhD

Blood (2018) 132 (Supplement 1): 1228.

https://doi.org/10.1182/blood-2018-99-120193

Published: 2018

Journal Articles

Diagnostic Concordance of Pathological Methods and Reports of Hematopathologists Compared to Local Nonspecialized Pathologists in the Diagnosis of Lymphoma in Mexico

Manuel Solano, MD, Luis Arteaga, Ramon Martinez Hernandez, MD, Alvaro Cabrero Garcia, David Gomez-Almaguer, MD, Adrian Alejandro Ceballos Lopez, Oscar De Jesus Perez, Maria Carmen Lome Maldonado, Petra Yuridia Lizeth Alvarado Bernal, Alejandra Zárate Osorno, Mariana Fernandez, Paula Barreyro, MD, Jose Alberto Regalado, Miguel Herrera-Rojas, MD

Blood (2018) 132 (Supplement 1): 4727.

https://doi.org/10.1182/blood-2018-99-117685

Published: 2018

Journal Articles

Socioeconomic Status and Outcomes Among Mexican Patients Undergoing Allogeneic Stem Cell Transplantation

Eucario Leon Rodriguez, MD, Monica M Rivera Franco

Blood (2018) 132 (Supplement 1): 4774.

https://doi.org/10.1182/blood-2018-99-110958

Published: 2018

NARROW

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL)

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Pediatric-Inspired Regimens Are Associated with Better Outcomes When Compared with Hypercvad in Hispanic Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Changing the Fate of Children with Acute Lymphoblastic Leukemia (ALL) in a Limited Resources Setting

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Tailored Prophylaxis in Mexican Pediatric Patients with Hemophilia a By Determining the Pharmacokinetics of Factor VIII

Imatinib (IMA) Low Dose Reduction Program (LDR) in Chronic Myeloid Leukemia Ph+ (CML Ph+) in a Single Reference Institution in Mexico City. Ongoing Preliminary Results

A Modified CALGB-10403 in Hispanic Adolescent and Young Adults with Philadelphia -Negative Acute Lymphoblastic Leukemia: Promising Results Despite a High-Rate of Metabolic and Hepatic Toxicities

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Role of Bone Marrow Infiltration and POD 24 in Follicular Lymphoma

Leukocytosis, but Not Thrombocytosis, May Constitute a Prothrombotic Pathway in Women with Ovarian Cancer: A Cohort Study

Diagnostic Concordance of Pathological Methods and Reports of Hematopathologists Compared to Local Nonspecialized Pathologists in the Diagnosis of Lymphoma in Mexico

Socioeconomic Status and Outcomes Among Mexican Patients Undergoing Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only